title: New developments in the treatment of ADHD.
authors.affiliation: Dept. of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
authors.forename: Joseph
authors.initials: J
authors.lastname: Biederman
authors.forename: Amy F T
authors.initials: AF
authors.lastname: Arnsten
authors.forename: Stephen V
authors.initials: SV
authors.lastname: Faraone
authors.forename: Alysa E
authors.initials: AE
authors.lastname: Doyle
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Spencer
authors.forename: Timothy E
authors.initials: TE
authors.lastname: Wilens
authors.forename: Margaret D
authors.initials: MD
authors.lastname: Weiss
authors.forename: Steven A
authors.initials: SA
authors.lastname: Safren
authors.forename: Larry
authors.initials: L
authors.lastname: Culpepper
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000628:therapy*; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D003000:Clonidine / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy / Q000639:trends; D016316:Guanfacine / Q000627:therapeutic use; D006801:Humans; D000077408:Modafinil; D018722:Nicotinic Agonists / Q000627:therapeutic use; D010819:Physician's Role; D011320:Primary Health Care; D011437:Propylamines / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000929:Antidepressive Agents, Tricyclic; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D018722:Nicotinic Agonists; D011437:Propylamines; D016642:Bupropion; D016316:Guanfacine; D000069445:Atomoxetine Hydrochloride; D003000:Clonidine; D000077408:Modafinil